Ipsen SA IPN.PA
Last Updated: Jul 21, 12:00 AM·XPAR
IPN.PA Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Ipsen SA is classified as halal.
HALAL
Report Source: 2025 2nd Quarter Report
Ipsen SA. Stock Analysis IPN.PA
France Health Care Large Cap Report: Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. The company employs 5,535 full-time employees The company went IPO on 2005-12-06. The firm operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.
Read More Ipsen SA (IPN.PA) Chart
Key Statistics of Ipsen SA (IPN.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€161.55Volume
136.15KP/E Ratio (TTM)
30.0952 Week Range
Market Cap
13.93BAvg. Volume
80.91KDividend Yield
0.87%Financial Metrics & Statements of Ipsen SA (IPN.PA)
Super Investors Invested in Ipsen SA (IPN.PA)
FAQ's for Ipsen SA (IPN.PA)
- As of July 2026, Ipsen SA IPN.PA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ipsen SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ipsen SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ipsen SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ipsen SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ipsen SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.